IGMPI India



Clarification on Health Canada’s issue by Dr Reddy’s Laboratories

Dr Reddy’s has clarified that the company has voluntarily detained all APIs and formulations based on APIs at the Srikakulam district of Andhra Pradesh intended to be used by the Canadians.

According to the company “Dr Reddy’s Products meet the quality standards of the regulators and the APIs and Finished drug products manufactured using these APIs is safe for the Canadian people and pose no risk to their health. The detention has been done keeping in view of the current regulations of Health Canada and has no impact on any activity of the plant.”

The company also said that they are working closely with the agency for satisfactory resolution of the matter.